Circ_0001068 Accelerates the Development of Ovarian Cancer by Promoting FXYD5 Expression Through Inhibiting Mir-149-5p Activity

Overview

Journal Discov Oncol

Publisher Springer

Specialty Oncology

Date 2024 Nov 12

PMID 39532790

Authors

Zhengqian Mou

Lingyan Ge

Saiya Ye

Zhiyong Gong

Affiliations

Soon will be listed here.

Abstract

Background: Ovarian cancer (OC) is one of the common malignancies of the female reproductive organs. Microarray analysis shows that circ_0001068 is upregulated in OC patients, however, its carcinogenic effect on OC development has not yet been revealed.

Methods: In this study, qRT-PCR and western blotting were used to determine the expression of circ_0001068, microRNA-149-5p (miR-149-5p) and domain containing ion transport regulator 5 (FXYD5). Clone formation was used to assess cell proliferation, and transwell assays were performed to analyze cell migration and invasion. Dual-luciferase reporter and pull down assays were used to verify the binding relationship between circ_0001068 and miR-149-5p or FXYD5. Mouse xenograft tumor formation was performed to validate the role of circ_0001068 in vivo.

Results: We found that the expression levels of circ_0001068 and FXYD5 were significantly increased in OC tissues and cell lines. Circ_0001068 knockdown significantly inhibited cell proliferation, migration, invasion, glycolysis, and glutamine metabolism. Circ_0001068 directly interacted with miR-149-5p, and the introduction of miR-149-5p mimics in OC cells partially reversed circ_0001068 knockdown-mediated effects. MiR-149-5p directly interacted with the 3'untranslated region (3'UTR) of FXYD5, and FXYD5 overexpression partially counteracted circ_0001068 knockdown-mediated effects in OC cells. Circ_0001068 knockdown inhibited xenograft tumor growth in vivo.

Conclusion: Our findings suggest that circ_0001068 promotes the malignant properties of OC cells by targeting the miR-149-5p/FXYD5 axis.

References

Mao W, Zhang Z . The Hsa_circ_0105558/miR-182-5p/ATF6 Cascade Affects HO-Triggered Oxidative Damage and Apoptosis of Human Lens Epithelial Cells. Biochem Genet. 2024; . DOI: 10.1007/s10528-024-10753-1. View

Guo J, Wang X, Sun L . MicroRNA-488 inhibits ovarian cancer cell metastasis through regulating CCNG1 and p53 expression. Eur Rev Med Pharmacol Sci. 2020; 24(6):2902-2910. DOI: 10.26355/eurrev_202003_20654. View

Zhang N, Jin Y, Hu Q, Cheng S, Wang C, Yang Z . Circular RNA hsa_circ_0078607 suppresses ovarian cancer progression by regulating miR-518a-5p/Fas signaling pathway. J Ovarian Res. 2020; 13(1):64. PMC: 7275507. DOI: 10.1186/s13048-020-00664-1. View

Li Y, Lin S, An N . Hsa_circ_0009910: oncogenic circular RNA targets microRNA-145 in ovarian cancer cells. Cell Cycle. 2020; 19(15):1857-1868. PMC: 7469526. DOI: 10.1080/15384101.2020.1731650. View

Aboutalebi H, Bahrami A, Soleimani A, Saeedi N, Rahmani F, Khazaei M . The diagnostic, prognostic and therapeutic potential of circulating microRNAs in ovarian cancer. Int J Biochem Cell Biol. 2020; 124:105765. DOI: 10.1016/j.biocel.2020.105765. View

Xie W, Liu L, He C, Zhao M, Ni R, Zhang Z . Circ_0002711 knockdown suppresses cell growth and aerobic glycolysis by modulating miR-1244/ROCK1 axis in ovarian cancer. J Biosci. 2021; 46. View

Hirschfeld M, Ge I, Rucker G, Waldschmidt J, Mayer S, Jager M . Mutually distinguishing microRNA signatures of breast, ovarian and endometrial cancers in vitro. Mol Med Rep. 2020; 22(5):4048-4060. DOI: 10.3892/mmr.2020.11466. View

Gajek A, Gralewska P, Marczak A, Rogalska A . Current Implications of microRNAs in Genome Stability and Stress Responses of Ovarian Cancer. Cancers (Basel). 2021; 13(11). PMC: 8199164. DOI: 10.3390/cancers13112690. View

Yu H, Pan S . MiR-202-5p suppressed cell proliferation, migration and invasion in ovarian cancer via regulating HOXB2. Eur Rev Med Pharmacol Sci. 2020; 24(5):2256-2263. DOI: 10.26355/eurrev_202003_20491. View

10.

Si H, Wang H, Xiao H, Fang Y, Wu Z . Anti-Tumor Effect of Celastrol on Hepatocellular Carcinoma by the circ_SLIT3/miR-223-3p/CXCR4 Axis. Cancer Manag Res. 2021; 13:1099-1111. PMC: 7872924. DOI: 10.2147/CMAR.S278023. View

11.

Chen Q, Zhang J, He Y, Wang Y . hsa_circ_0061140 Knockdown Reverses FOXM1-Mediated Cell Growth and Metastasis in Ovarian Cancer through miR-370 Sponge Activity. Mol Ther Nucleic Acids. 2018; 13:55-63. PMC: 6143755. DOI: 10.1016/j.omtn.2018.08.010. View

12.

Huang K, Liu D, Su C . Circ_0007841 accelerates ovarian cancer development through facilitating MEX3C expression by restraining miR-151-3p activity. Aging (Albany NY). 2021; 13(8):12058-12066. PMC: 8109085. DOI: 10.18632/aging.202911. View

13.

Brown J, Friedlander M, Backes F, Harter P, OConnor D, de La Motte Rouge T . Gynecologic Cancer Intergroup (GCIG) consensus review for ovarian germ cell tumors. Int J Gynecol Cancer. 2014; 24(9 Suppl 3):S48-54. DOI: 10.1097/IGC.0000000000000223. View

14.

Li M, Chi C, Zhou L, Chen Y, Tang X . Circular PVT1 regulates cell proliferation and invasion via miR-149-5p/FOXM1 axis in ovarian cancer. J Cancer. 2021; 12(2):611-621. PMC: 7738991. DOI: 10.7150/jca.52234. View

15.

Wang X, Yao Y, Jin M . Circ-0001068 is a novel biomarker for ovarian cancer and inducer of PD1 expression in T cells. Aging (Albany NY). 2020; 12(19):19095-19106. PMC: 7732319. DOI: 10.18632/aging.103706. View

16.

Thusgaard C, Korsholm M, Koldby K, Kruse T, Thomassen M, Jochumsen K . Epithelial ovarian cancer and the use of circulating tumor DNA: A systematic review. Gynecol Oncol. 2021; 161(3):884-895. DOI: 10.1016/j.ygyno.2021.04.020. View

17.

Foo T, George A, Banerjee S . PARP inhibitors in ovarian cancer: An overview of the practice-changing trials. Genes Chromosomes Cancer. 2020; 60(5):385-397. DOI: 10.1002/gcc.22935. View

18.

Zhang H, Lu B . microRNAs as biomarkers of ovarian cancer. Expert Rev Anticancer Ther. 2020; 20(5):373-385. DOI: 10.1080/14737140.2020.1760095. View

19.

Tassi R, Gambino A, Ardighieri L, Bignotti E, Todeschini P, Romani C . FXYD5 (Dysadherin) upregulation predicts shorter survival and reveals platinum resistance in high-grade serous ovarian cancer patients. Br J Cancer. 2019; 121(7):584-592. PMC: 6889357. DOI: 10.1038/s41416-019-0553-z. View

20.

Wei S, Qi L, Wang L . Overexpression of circ_CELSR1 facilitates paclitaxel resistance of ovarian cancer by regulating miR-149-5p/SIK2 axis. Anticancer Drugs. 2021; 32(5):496-507. DOI: 10.1097/CAD.0000000000001058. View